Anthony Edward Samir, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Elasticity Imaging Techniques | 26 | 2024 | 392 | 9.780 |
Why?
|
Ultrasonography | 28 | 2024 | 5971 | 2.900 |
Why?
|
Thyroid Nodule | 10 | 2022 | 764 | 2.330 |
Why?
|
Liver Cirrhosis | 15 | 2024 | 1935 | 2.320 |
Why?
|
Liver | 20 | 2024 | 7528 | 1.390 |
Why?
|
Phantoms, Imaging | 9 | 2023 | 2526 | 1.370 |
Why?
|
Ultrasonography, Interventional | 5 | 2023 | 1496 | 1.250 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2020 | 198 | 1.240 |
Why?
|
Thyroid Neoplasms | 7 | 2022 | 2332 | 1.220 |
Why?
|
Elastic Modulus | 3 | 2017 | 211 | 1.090 |
Why?
|
Transducers | 3 | 2023 | 244 | 1.060 |
Why?
|
Thyroid Gland | 5 | 2021 | 1170 | 1.010 |
Why?
|
Liver Diseases | 5 | 2018 | 1297 | 1.010 |
Why?
|
Fatty Liver | 2 | 2022 | 790 | 0.930 |
Why?
|
Acoustics | 2 | 2023 | 242 | 0.910 |
Why?
|
Biopsy, Fine-Needle | 8 | 2022 | 1118 | 0.860 |
Why?
|
Thyroid Diseases | 2 | 2016 | 386 | 0.820 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2024 | 9001 | 0.730 |
Why?
|
Portal Vein | 2 | 2021 | 431 | 0.710 |
Why?
|
Needles | 1 | 2023 | 451 | 0.690 |
Why?
|
Reproducibility of Results | 20 | 2024 | 20100 | 0.650 |
Why?
|
Ultrasonography, Mammary | 1 | 2021 | 239 | 0.640 |
Why?
|
Pulsatile Flow | 1 | 2020 | 321 | 0.630 |
Why?
|
Abdomen | 3 | 2020 | 1128 | 0.600 |
Why?
|
Renal Artery Obstruction | 1 | 2019 | 219 | 0.580 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 3359 | 0.570 |
Why?
|
Catheterization, Central Venous | 1 | 2021 | 526 | 0.550 |
Why?
|
Endometrium | 1 | 2019 | 403 | 0.540 |
Why?
|
Neck | 1 | 2021 | 734 | 0.520 |
Why?
|
Adenoma, Oxyphilic | 1 | 2017 | 148 | 0.510 |
Why?
|
Sensitivity and Specificity | 15 | 2021 | 14665 | 0.500 |
Why?
|
Urinary Calculi | 1 | 2015 | 90 | 0.500 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2016 | 323 | 0.500 |
Why?
|
Radiology | 4 | 2018 | 2113 | 0.490 |
Why?
|
Elasticity | 4 | 2023 | 655 | 0.490 |
Why?
|
Pressure | 1 | 2017 | 1154 | 0.440 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1204 | 0.430 |
Why?
|
Prostate | 2 | 2019 | 1773 | 0.430 |
Why?
|
Echinococcus granulosus | 1 | 2012 | 11 | 0.420 |
Why?
|
Echinococcosis, Hepatic | 1 | 2012 | 24 | 0.420 |
Why?
|
Splenic Diseases | 1 | 2012 | 90 | 0.390 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2578 | 0.380 |
Why?
|
Biopsy, Needle | 3 | 2016 | 1626 | 0.380 |
Why?
|
Humans | 77 | 2024 | 761596 | 0.370 |
Why?
|
Prostatic Neoplasms | 3 | 2020 | 11122 | 0.370 |
Why?
|
Testicular Neoplasms | 1 | 2017 | 799 | 0.360 |
Why?
|
Kidney | 5 | 2020 | 7048 | 0.350 |
Why?
|
Image Enhancement | 4 | 2015 | 2884 | 0.350 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 823 | 0.350 |
Why?
|
Kidney Neoplasms | 7 | 2017 | 4251 | 0.340 |
Why?
|
Biopsy | 6 | 2023 | 6766 | 0.330 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.320 |
Why?
|
Radiography | 2 | 2017 | 6965 | 0.320 |
Why?
|
Amyloidosis | 1 | 2015 | 817 | 0.310 |
Why?
|
Microbubbles | 3 | 2024 | 135 | 0.310 |
Why?
|
Male | 42 | 2024 | 360846 | 0.310 |
Why?
|
Occupational Diseases | 1 | 2017 | 1490 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36426 | 0.300 |
Why?
|
Middle Aged | 33 | 2024 | 220921 | 0.300 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 641 | 0.290 |
Why?
|
Observer Variation | 3 | 2019 | 2606 | 0.280 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12973 | 0.280 |
Why?
|
Stents | 1 | 2019 | 3179 | 0.280 |
Why?
|
Female | 37 | 2024 | 392705 | 0.260 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2244 | 0.260 |
Why?
|
Algorithms | 6 | 2024 | 14033 | 0.250 |
Why?
|
Venous Thrombosis | 1 | 2015 | 1303 | 0.250 |
Why?
|
Carcinoma, Renal Cell | 3 | 2017 | 3165 | 0.250 |
Why?
|
Kidney Diseases | 2 | 2020 | 2091 | 0.250 |
Why?
|
Aged | 26 | 2024 | 169310 | 0.250 |
Why?
|
Adult | 27 | 2024 | 221210 | 0.250 |
Why?
|
Retrospective Studies | 17 | 2024 | 80647 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2015 | 2242 | 0.230 |
Why?
|
Radiology, Interventional | 2 | 2019 | 476 | 0.220 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15843 | 0.210 |
Why?
|
Respiratory Protective Devices | 1 | 2023 | 47 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20568 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.210 |
Why?
|
Sheep | 3 | 2020 | 1440 | 0.190 |
Why?
|
Aged, 80 and over | 14 | 2020 | 58984 | 0.190 |
Why?
|
Femoral Vein | 1 | 2021 | 153 | 0.190 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9420 | 0.180 |
Why?
|
Contrast Media | 7 | 2020 | 5307 | 0.180 |
Why?
|
Swine | 2 | 2021 | 5915 | 0.170 |
Why?
|
Pilot Projects | 4 | 2018 | 8633 | 0.170 |
Why?
|
Young Adult | 10 | 2020 | 59260 | 0.170 |
Why?
|
Integrin alphaVbeta3 | 1 | 2020 | 105 | 0.170 |
Why?
|
Prospective Studies | 8 | 2024 | 54423 | 0.160 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 119 | 0.160 |
Why?
|
Reference Standards | 1 | 2022 | 1003 | 0.160 |
Why?
|
Peptides, Cyclic | 1 | 2020 | 392 | 0.150 |
Why?
|
Physics | 1 | 2018 | 91 | 0.150 |
Why?
|
Critical Pathways | 2 | 2018 | 474 | 0.150 |
Why?
|
Feasibility Studies | 3 | 2019 | 5247 | 0.140 |
Why?
|
Gelatin | 1 | 2019 | 220 | 0.140 |
Why?
|
Fibrosis | 3 | 2023 | 2049 | 0.140 |
Why?
|
Urinary Bladder | 1 | 2023 | 1152 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5368 | 0.140 |
Why?
|
Sound | 2 | 2017 | 257 | 0.140 |
Why?
|
Renal Artery | 1 | 2019 | 351 | 0.140 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2020 | 2297 | 0.140 |
Why?
|
Shear Strength | 1 | 2017 | 160 | 0.130 |
Why?
|
Adolescent | 9 | 2021 | 88326 | 0.130 |
Why?
|
Thymus Gland | 1 | 2021 | 1243 | 0.130 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2015 | 43 | 0.130 |
Why?
|
Rectum | 1 | 2020 | 892 | 0.120 |
Why?
|
Subtraction Technique | 2 | 2015 | 512 | 0.120 |
Why?
|
Perfusion | 2 | 2018 | 1373 | 0.120 |
Why?
|
Orchiectomy | 1 | 2017 | 463 | 0.120 |
Why?
|
Area Under Curve | 1 | 2018 | 1638 | 0.110 |
Why?
|
Computer Systems | 1 | 2015 | 470 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15266 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2016 | 248 | 0.110 |
Why?
|
Radiology Information Systems | 1 | 2018 | 529 | 0.110 |
Why?
|
Liver Neoplasms | 3 | 2020 | 4317 | 0.110 |
Why?
|
Radiographic Image Enhancement | 2 | 2008 | 876 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21019 | 0.110 |
Why?
|
Testis | 1 | 2017 | 794 | 0.110 |
Why?
|
Animals | 9 | 2024 | 168475 | 0.110 |
Why?
|
Ultrasonography, Doppler | 1 | 2015 | 462 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 697 | 0.100 |
Why?
|
Molecular Imaging | 2 | 2020 | 815 | 0.100 |
Why?
|
Breast | 1 | 2021 | 1967 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2017 | 1674 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1200 | 0.100 |
Why?
|
Positron-Emission Tomography | 2 | 2020 | 6484 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26129 | 0.090 |
Why?
|
Propensity Score | 1 | 2019 | 1913 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 909 | 0.090 |
Why?
|
Musculoskeletal Diseases | 1 | 2017 | 598 | 0.090 |
Why?
|
Cytodiagnosis | 1 | 2013 | 447 | 0.080 |
Why?
|
ROC Curve | 2 | 2015 | 3578 | 0.080 |
Why?
|
Adipose Tissue, Brown | 1 | 2015 | 764 | 0.080 |
Why?
|
Cold Temperature | 2 | 2015 | 785 | 0.080 |
Why?
|
Aorta | 1 | 2017 | 2041 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1007 | 0.080 |
Why?
|
Ureteral Diseases | 1 | 2008 | 63 | 0.080 |
Why?
|
Pancreas | 1 | 2015 | 1691 | 0.080 |
Why?
|
Cathartics | 1 | 2008 | 127 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 193 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2009 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3424 | 0.070 |
Why?
|
Angiomyolipoma | 1 | 2008 | 187 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3322 | 0.070 |
Why?
|
Preoperative Care | 1 | 2015 | 2242 | 0.070 |
Why?
|
Iodine | 1 | 2008 | 288 | 0.070 |
Why?
|
Lung | 1 | 2024 | 10002 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2009 | 2751 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2024 | 3600 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1222 | 0.060 |
Why?
|
Child | 4 | 2021 | 80158 | 0.060 |
Why?
|
Phosphates | 1 | 2008 | 770 | 0.060 |
Why?
|
Adenoma | 1 | 2015 | 2163 | 0.060 |
Why?
|
Inflammation | 1 | 2023 | 10774 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15733 | 0.060 |
Why?
|
Infant | 2 | 2015 | 36193 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39106 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11076 | 0.050 |
Why?
|
Creatinine | 1 | 2008 | 1899 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Filtration | 1 | 2023 | 228 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Diagnostic Imaging | 2 | 2024 | 3530 | 0.050 |
Why?
|
Mice | 4 | 2024 | 81539 | 0.040 |
Why?
|
Masks | 1 | 2023 | 208 | 0.040 |
Why?
|
Colonoscopy | 1 | 2008 | 1394 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 940 | 0.040 |
Why?
|
Chronic Disease | 1 | 2014 | 9319 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8554 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18255 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12953 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2645 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 457 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 22176 | 0.040 |
Why?
|
Brain | 1 | 2024 | 27121 | 0.040 |
Why?
|
North America | 1 | 2021 | 1276 | 0.040 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 418 | 0.040 |
Why?
|
Glucose | 1 | 2008 | 4347 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2018 | 1625 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2008 | 1924 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2008 | 3313 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2467 | 0.030 |
Why?
|
Time Factors | 3 | 2012 | 39969 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 26202 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.030 |
Why?
|
Child, Preschool | 2 | 2015 | 42232 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7391 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23996 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 74213 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2024 | 3465 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 233 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1186 | 0.030 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Iopamidol | 1 | 2012 | 186 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2015 | 1371 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 6938 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2008 | 182 | 0.020 |
Why?
|
Thyrotropin | 1 | 2012 | 834 | 0.020 |
Why?
|
Urine | 1 | 2008 | 362 | 0.020 |
Why?
|
England | 1 | 2008 | 526 | 0.020 |
Why?
|
Hydronephrosis | 1 | 2008 | 271 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2012 | 908 | 0.020 |
Why?
|
Cohort Studies | 3 | 2015 | 41495 | 0.020 |
Why?
|
Nausea | 1 | 2008 | 679 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1498 | 0.020 |
Why?
|
Hemodynamics | 1 | 2015 | 4160 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2008 | 1008 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13510 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1071 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3415 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4853 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
Software | 1 | 2012 | 4434 | 0.010 |
Why?
|
Reoperation | 1 | 2008 | 4303 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8833 | 0.010 |
Why?
|
Boston | 1 | 2008 | 9327 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2009 | 64685 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21355 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2008 | 9280 | 0.010 |
Why?
|
United States | 1 | 2011 | 72340 | 0.000 |
Why?
|